Apyx Medical (NASDAQ:APYX) and SECTOR 10 (OTCMKTS:SECI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.
Institutional and Insider Ownership
39.8% of Apyx Medical shares are held by institutional investors. 5.7% of Apyx Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Apyx Medical and SECTOR 10’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings and recommmendations for Apyx Medical and SECTOR 10, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Apyx Medical presently has a consensus target price of $10.00, indicating a potential upside of 31.06%. Given Apyx Medical’s higher probable upside, research analysts plainly believe Apyx Medical is more favorable than SECTOR 10.
Earnings and Valuation
This table compares Apyx Medical and SECTOR 10’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Apyx Medical||$16.69 million||15.56||$64.01 million||($0.29)||-26.31|
Apyx Medical has higher revenue and earnings than SECTOR 10.
Apyx Medical beats SECTOR 10 on 6 of the 8 factors compared between the two stocks.
About Apyx Medical
Apyx Medical Corporation provides products in the cosmetic and surgical markets worldwide. The company markets Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. Its Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and the J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
About SECTOR 10
Sector 10, Inc., a development stage company, markets the mobile response unit and stationary response unit products, and the PLX-3D technology. The company was founded in 2002 and is based in Salt Lake City, Utah.
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.